Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Operating Income data on record, last reported at $5.3 million in Q2 2025.

  • For Q2 2025, Operating Income rose 147.88% year-over-year to $5.3 million; the TTM value through May 2025 reached -$17.2 million, down 94.99%, while the annual FY2025 figure was -$17.2 million, 94.99% down from the prior year.
  • Operating Income reached $5.3 million in Q2 2025 per LFCR's latest filing, up from -$9.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $18.6 million in Q2 2021 and bottomed at -$11.6 million in Q3 2024.
  • Average Operating Income over 5 years is -$1.4 million, with a median of -$2.4 million recorded in 2021.
  • Peak YoY movement for Operating Income: soared 4247.22% in 2021, then plummeted 13302.74% in 2022.
  • A 5-year view of Operating Income shows it stood at $7.3 million in 2021, then tumbled by 173.13% to -$5.4 million in 2022, then soared by 72.29% to -$1.5 million in 2023, then tumbled by 32.1% to -$2.0 million in 2024, then surged by 371.92% to $5.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were $5.3 million in Q2 2025, -$9.0 million in Q1 2025, and -$2.0 million in Q4 2024.